Protheragen is proud to release the launch of its comprehensive vaccine development solutions tailored to advance research and development in the field of infectious diseases. This strategic initiative aims to accelerate the creation of effective vaccines to combat emerging and re-emerging infectious threats.
Infectious diseases are disorders caused by organisms — such as bacteria,...
Protheragen, a dedicated preclinical research service provider specializing in rare diseases, announces its comprehensive diagnostic development services aimed at empowering researchers in the realm of rare disease research and drug development. These diagnostic services are designed to support the scientific community in identifying, understanding, and ultimately treating rare diseases that...
Rare diseases, which affect a small percentage of the population, pose unique challenges for researchers due to their limited understanding and lack of available treatment options. Rare disease models are utilized to recreate the pathophysiological processes and symptoms of rare diseases in a laboratory setting. These models offer researchers a controlled environment to investigate the...
Protheragen, a leading CRO in rare disease research, is proud to announce the launch of its groundbreaking disease model development platform. This platform is specifically designed to develop 2D cell culture, 3D organoid, and animal models to accelerate research and therapy development for rare diseases. This state-of-the-art platform combines cutting-edge technology, extensive biological...
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek